EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Editorial Archive

Conducting Clinical Trials in the Parallel Virtual Universe

Quantitative systems pharmacology (QSP) and physiologically based pharmacokinetic (PBPK) modelling can be employed to create a parallel virtual workflow throughout d...
19 April 2024 Editorial Archive | Volume 16 Issue 1 clinical | Conducting
Continue Reading →
Editorial Archive

Advancing Research and Development of Multi-indication and Combination Therapies for Obesity

Obesity is commonly defined as excess fat accumulation that puts someone at a higher risk for adverse health outcomes.1 The simplicity of this definition can be misl...
19 April 2024 Editorial Archive | Volume 16 Issue 1 accumulation | advancing
Continue Reading →
Editorial Archive

Generative AI is Revolutionising Life Sciences, And We’re Just Scratching the Surface

On average, it takes about seven years to develop a new drug and bring it to market. For ambitious life science businesses, generative AI’s ability to generate insig...
19 April 2024 Editorial Archive | Volume 16 Issue 1 AI | clinical
Continue Reading →
Volume 15 Issue 4

Enhancing the Data Journey in Oncology Clinical Trials

Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation of new treatments and next-generation therapies for pat...
24 January 2024 Volume 15 Issue 4 clinical | data
Continue Reading →
Volume 15 Issue 4

Diabesity: Implications for Treatment and Drug Development

The term “diabesity” has been used to refer to the twin pandemics of type 2 diabetes (T2D) and obesity.1 It was originally used after experiments showed that overfee...
24 January 2024 Volume 15 Issue 4 development | Diabesity
Continue Reading →
Volume 15 Issue 4

Developing Effective Supply Chain Strategies Utilising Forecasting Technology

Drug development has evolved considerably over recent decades, along with the clinical supply chains that underpin the continued advancement of human health. In t...
24 January 2024 Volume 15 Issue 4 chain | clinical supply chains
Continue Reading →
Volume 15 Issue 2

Clinical Trial Technology Trends: The Top 5 Innovations Shaping Clinical Trials in 2023

Clinical trials play a crucial role in the development and approval of new medical treatments and drugs. As technology continues to advance, Clinical Trial Technolog...
6 July 2023 Volume 15 Issue 2 approval | clinical
Continue Reading →
Volume 14 Issue 6

Taking a Long-Term Approach to Improving Vaccine Trial Recruitment

The groundbreaking mRNA technology used in the COVID-19 vaccine has potential applications in preventing a number of other infectious diseases and is ushering in a wa...
30 November 2022 Volume 14 Issue 6 cost | COVID
Continue Reading →
Europe

Speeding Drug Development with Clinical Trials in a Dish

The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory hurdles. Any technology or methodology that can exped...
6 June 2018 Europe clinical | development
Continue Reading →
news

INC Research/inVentiv Health Becomes Syneos HealthTM

INC Research/inVentiv Health (Nasdaq: INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of t...
4 January 2018 news | North America brand | clinical
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte